Table 3. Publications on the prevalence of DTC in acromegaly.

Reference	Patients n	M/F (%)	Prevalence of goiter (%)	Prevalence of DTC (%) (n PTC/n FTC)	M/F with DTC	DTC follow-up (months)
Popovic V et al., 1998 [10]	220	38%/62%	n.a.	1.4% (3 PTC/0 FTC)	n.a.	n.a.
Gasperi M et al., 2002 [11]	258	43%/57%	72%	1.2% (3 PTC/0 FTC)	n.a.	n.a.
Herrmann BL et al., 2004 [12]	73	n.a.	82%	5.5% (3 PTC/1 FTC)	n.a.	n.a.
Tita P et al., 2005 [13]	125	44%/56%	82%	5.6% (5 PTC/2 FTC)	4/3	6–140
Kurimoto M et al., 2008 [3]	140	39%/61%	57%	3.6% (4 PTC/1 n.a)	1/3	n.a.
Gullu BE et al., 2010 [14]	105	38%/62%	62%	4.8% (5 PTC/0 FTC)	5/0	n.a.
Baldys-Waligorska A et al., 2010 [15]	101	30%/70%	63%	3% (1 PTC/2 FTC)	n.a.	n.a.
Dos Santos MCC et al., 2013 [16]	124	39%/61%	74%	7.3% (9 PTC/0 FTC)	3/6	n.a.
Dagdelen S et al., 2013 [17]	160	51%/49%	80%	10.6% (13 PTC/3 FTC/1 PTC-FTC)	8/9	n.a.
Present paper	113	44%/56%	73%	10.6% (10 PTC/2 FTC)	1/11	7–396
Overall	1419	41%/59%	72%	4.8% (57 PTC/10 FTC)*	14/23

Legend: PTC: papillary thyroid carcinoma, FTC: follicular thyroid carcinoma; M: Male; F: Female.